JAGSONPAL PHARMACEUTICALS
Back to Cashflow Statement
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹55 Cr | ₹35 Cr | ₹47 Cr | ₹6.91 Cr | ₹28 Cr |
What is the latest Cash Flow from Operating Activities ratio of JAGSONPAL PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹55 Cr |
| Mar2024 | ₹35 Cr |
| Mar2023 | ₹47 Cr |
| Mar2022 | ₹6.91 Cr |
| Mar2021 | ₹28 Cr |
How is Cash Flow from Operating Activities of JAGSONPAL PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹55 Cr | 57.25 | |
| Mar2024 | ₹35 Cr | -24.63 | |
| Mar2023 | ₹47 Cr | 574.79 | |
| Mar2022 | ₹6.91 Cr | -75.50 | |
| Mar2021 | ₹28 Cr | - | |
Compare Cash Flow from Operating Activities of peers of JAGSONPAL PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JAGSONPAL PHARMACEUTICALS | ₹1,090.5 Cr | -5.4% | -4% | -21.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JAGSONPAL PHARMACEUTICALS | -5.4% |
-4% |
-21.2% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses